Clark Golestani
Managing Director
C Sensei Group
Clark Golestani has over 35 years of experience in health, life sciences, and technology. He currently serves as the Managing Director of C Sensei Group, LLC, an advisory services firm, and holds positions as a Senior Advisor to New Mountain Capital, Managing Partner of the K2 Access Fund, and Industry Advisor to Advent.
Mr. Golestani serves as Chairman of the Board for Zapata Quantum and is an independent director for eMids, Emmes, Iridius.ai, and Otonoma. He actively advises companies and funds on strategies spanning company, go-to-market, data, digital, technology, and transformation in the healthcare and life sciences sectors.
Previously, Clark retired from Merck as President, Emerging Businesses and Global CIO, where he led the company's global IT organization and digital health portfolio. He holds a degree in Management Science from the MIT Sloan School of Management.